logo

Crispr Therapeutics Ag (CRSP)



Trade CRSP now with
  Date
  Headline
11/9/2018 7:12:04 AM CRISPR Therapeutics And MaxCyte Expand Clinical And Commercial License Agreement Into Oncology
9/20/2018 8:55:54 PM CRISPR Therapeutics Announces Pricing Of Underwritten Public Offering Of 4.21 Mln Shares At $47.50/shr
9/19/2018 4:13:12 PM CRISPR Therapeutics Announces Proposed Public Offering Of Common Shares
9/17/2018 8:14:06 AM CRISPR Therapeutics And ViaCyte Announce Strategic Collaboration To Develop Gene-Edited Stem Cell-Derived Therapy
6/19/2018 9:10:02 AM CRISPR, Intellia Therapeutics And Caribou Biosciences Announce Grant Of US Patent For CRISPR/Cas9 Genome Editing
5/8/2018 8:12:44 AM CRISPR Therapeutics Q1 Net Loss $28.3 Mln Vs Loss $21.5 Mln Last Year
4/4/2018 4:05:02 PM CRISPR Therapeutics Appoints Steve Caffé As Head Of Regulatory Affairs
1/4/2018 7:19:38 PM CRISPR Therapeutics Prices Public Offering Of 5 Mln Shares At $22.75/sr